Accelerate Oncology (Cancer) Revolution

Goldbug Strategies is a medical consulting company.

FivepHusion develops Deflexifolâ„¢, aiming to optimize chemotherapy for better cancer treatment outcomes.

RegulomeX revolutionizing drug target identification and validation with precision genomic insights

ToMore Vision is a CancerTech company providing oncology teams AI insights to enhance diagnostic accuracy and improve patient outcomes.

PD Theranostics focuses on developing AI-guided algorithms for superior therapeutic decision-making and truly personalized medicine.

METHYS Dx develops methylation marker panels for ctDNA characterization in liquid biopsies, focusing on non-invasive cancer monitoring.

Wholomics specializes in developing minimally-invasive liquid biopsy tests for cancer detection and precision medicine.

KeyZell is a biotechnology company that offers oncology solutions based on precision medicine that improves the lives of patients.

AeproMED revolutionizes healthcare with personalized medicine using advanced aerosol technology and integrated bio-signal detection.

Oncolines is a precision medicine services company specialising in oncology and cancer immunotherapy.

Predicting Med offers diagnostic, prognostic, and theranostic services allowing the implementation of personalized medicines.

Zhongke Microbiology is a precision cancer prevention center that provides remote consultation services.

OrganOmics engages in drug discovery rooted in precision medicine.

Jingjiahang is an innovative biopharmaceutical company focusing on the research and development of new targeted radiopharmaceuticals.

Genegoggle is a precision medicine biotech company.

InnoMab uses big data and AI calculations to develop targeted drugs and precision medicine tools.